Donoghue Forlines’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Donoghue Forlines's REGN Position: Q3 2026 in Review
Donoghue Forlines opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 4,384 shares worth $3.32M. The stake represents 0.84% of the portfolio and ranks #46 among its holdings. This is a return to the name: Donoghue Forlines previously reported a position in REGN as recently as Q1 2023.
Donoghue Forlines first reported a position in REGN in Q3 2018 and has held it in 9 quarters since. 1,426 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Donoghue Forlines held 4,384 shares of Regeneron Pharmaceuticals worth $3.32M as of Q3 2026.
- Regeneron Pharmaceuticals was a new Donoghue Forlines position in Q3 2026.
- Regeneron Pharmaceuticals made up 0.84% of Donoghue Forlines's portfolio in Q3 2026, its #46 holding.
- Donoghue Forlines first reported a position in Regeneron Pharmaceuticals in Q3 2018 and has held it in 9 quarters since.
- 1,426 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Donoghue Forlines's 13F filing for Q3 2026, filed 2 Nov 2026.